Sonova presents AI products: UBS targets Sonova stock at CHF 273

Published on 10/20/2026 at 13:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Sonova's half-year results arrive November 12, 2026 with guidance in view. Sonova stock costs EUR 300.55 on October 20, 2026.

Artificial intelligence and guidance

Sonova presented Roger On Sphere on October 14, 2026, extending artificial intelligence beyond hearing aids.
UBS expects 7.00 to 9.00 percent revenue growth at constant currencies with the half-year results.
Sonova stock trades at EUR 300.55 at 1:39 p.m. CEST at Lang & Schwarz on October 20, 2026.
Sonova plans to publish its half-year results on November 12, 2026.

Professional architectural photography of a modern medical technology corporate headquarters building featuring floor-to-ceiling glass facade with structural transparency revealing bright open office floors, surrounded by manicured greenery and a reflecti — Sonova CH0012549785: Modernes Med-Tech-Headquarter mit transparenter Glasfassade, Spiegelbecken und Grünanlagen bei goldenem Abendlicht, Illustration mit AI erstellt.

Sonova Holding AG (CH0012549785) presented artificial-intelligence products on October 14, 2026, while UBS set a CHF 273.00 price target for Sonova stock ahead of the company's half-year results. The product push extends beyond hearing aids, but the November update will test whether growth assumptions are catching up.

AI moves beyond hearing aids

According to Sonova, Phonak introduced Roger On Sphere on October 14, 2026, a remote microphone using a deep neural network to separate speech from background noise. The same investor page describes Advanced Bionics' Integro cochlear-implant platform as another product with artificial-intelligence processing.

The chronology is clear. On September 29, 2026, Sonova ranked first among the top 100 large Swiss companies in an innovation ranking, according to MarketScreener. On October 14, 2026, the company presented new AI applications beyond hearing aids. On October 19, 2026, UBS put its target at CHF 273.00.

What does UBS expect from results?

UBS expects Sonova to raise its outlook with the half-year results on November 12, 2026. In its October 19, 2026 report, Investing.com said the bar was 7.00 to 9.00 percent revenue growth and 9.00 to 11.00 percent core EBIT growth, both at constant currencies, compared with previous ranges of 5.00 to 8.00 percent and 7.00 to 10.00 percent.

UBS also estimated a 4.00 percent uplift to consensus core EBIT for the year. Its CHF 273.00 target was 3.00 percent above the current Swiss quote cited in the report, while the bank warned that expectations were elevated. That makes the November figures more important than the product headlines alone.

November brings the next test

Sonova's financial calendar lists November 12, 2026, for publication of its half-year results and November 16, 2026, for the following roadshow. The company reported CHF 3.6 billion in sales and CHF 546.0 million in income after taxes for fiscal year 2025/26, according to its investor overview.

At Lang & Schwarz, Sonova stock was trading at EUR 300.55 on October 20, 2026, at 1:39 p.m. CEST. The primary listing is on the SIX Swiss Exchange, where the finance quote showed CHF 277.60 at 11:30 a.m. UTC on October 20, 2026, an intraday value.

The further course of trading is shown by the continuously updated real-time quote of Sonova stock.